XML 146 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1

Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Share-based Compensation, Activity

The following table presents our total stock-based compensation expense:

			Year Ended
			2024						2023						2022
Employee stock-based compensation expense
Pre-tax (1)			$	2,097					$	1,082					$	1,230
Post-tax (2)			1,657						855						972
Director stock-based compensation expense
Pre-tax (1)			448						174						158
Post-tax (2)			354						137						125

(1) This table does not include withholding of vested shares for tax liabilities, which totaled $1,359,000, $24,000 and $25,000 in 2024, 2023, and 2022, respectively.

(2) The after-tax amounts are determined using the 21% corporate federal tax rate.

Schedule of Nonvested Share Activity

The following table presents certain information related to the activity of our non-vested common stock grants:

			Number of Restricted Shares						Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2021			336,596						$	6.99
Granted			907,907						1.97
Less: Forfeited			383,876						3.43
Less: Vested			146,388						6.00
Outstanding as of December 31, 2022			714,239						$	2.73
Granted			45,000						5.25
Less: Forfeited			132,259						3.16
Less: Vested			181,334						3.25
Outstanding as of December 31, 2023			445,646						$	2.64
Granted (1)			598,713						7.41
Less: Forfeited			1,476						4.56
Less: Vested			436,472						3.36
Outstanding as of December 31, 2024			606,411						$	6.23

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following weighted-average assumptions were used to value the stock options granted:

			2024						2023
Expected annual dividend yield			—		%				—		%
Expected volatility			86.92		%				80.84		%
Risk-free interest rate			4.37		%				3.44		%
Expected term			6		years				6		years

Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity

The following table presents certain information related to the activity of our non-vested stock option grants:

			Number of Stock Options						Weighted Average Exercise Prices						Weighted Average Remaining Contractual Term (years)						Aggregate Intrinsic Value (3)
Outstanding as of December 31, 2021			1,147,215						$	4.80					9.49						$	792,000
Granted			635,643						1.70						—						—
Less: Forfeited			426,480						2.91						—						—
Less: Exercised			—						—						—						—
Less: Expired			105,693						6.65						—						—
Outstanding as of December 31, 2022			1,250,685						$	3.71					7.66						$	—
Vested as of December 31, 2022			532,797						$	7.26					8.03						$	—
Exercisable as of December 31, 2022			432,786						$	5.25					5.10						$	—
Outstanding as of December 31, 2022			1,250,685						$	3.71					7.66						$	—
Granted			—						—						—						—
Less: Forfeited			40,000						3.46						—						—
Less: Exercised			20,000						3.46						—						—
Less: Expired			161,925						3.05						—						—
Outstanding as of December 31, 2023			1,028,760						$	3.83					7.80						$	6,151,000
Vested as of December 31, 2023			920,818						$	4.78					7.56						$	3,071,000
Exercisable as of December 31, 2023			580,568						$	4.78					7.56						$	3,071,000
Outstanding as of December 31, 2023			1,028,760						$	3.83					7.80						$	6,151,000
Granted(1)			196,275						4.82						—						—
Less: Forfeited			—						—						—						—
Less: Exercised			95,000						2.35						—						—
Less: Expired			—						—						—						—
Outstanding as of December 31, 2024			1,130,035						$	4.12					7.21						$	10,202,000
Vested as of December 31, 2024 (2)			1,276,019						$	4.30					6.79						$	7,501,000
Exercisable as of December 31, 2024			840,768						$	4.30					6.79						$	7,501,000

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration